J Melville Engle insider trades: Predictive Oncology (POAI) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where J reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 24, 2022 | POAI | ↑ Buy | 159,500 | $0.37 | $59K | Direct | May 24, 2022 (0d) |
| Mar 10, 2011 | KOOL | ↑ Buy | 22,500 | $2.30 | $52K | Direct | Mar 10, 2011 (0d) |
| Sep 25, 2009 | KOOL | ↑ Buy | 100,000 | $0.57 | $57K | Direct | Sep 28, 2009 (3d) |
| May 12, 2009 | KOOL | ↑ Buy | 100,000 | $0.55 | $55K | Direct | May 12, 2009 (0d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About J Melville Engle's insider trades
J Melville Engle is an insider at Predictive Oncology (POAI). Since May 12, 2009, J has reported 4 open-market purchases worth $223K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (30 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every POAI insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.